BDJ
BlackRock Enhanced Equity Dividend Trust
$9.11
+0.16%
$1.6B
No data for this timeframe.
Vol
Market Cap$1.6B
Cap SizeSmall Cap
Inst. Holders3 funds
Inst. Value$63.1M
Inst. Activity0 buys / 1 sells
Recent Activity
Apr 1, 2026
Insider
Harris Stayce D. sold 555.94 shares
Director @ $8.75 ($4.9K)
Apr 1, 2026
Insider
Steinmetz Arthur Philip sold 781.81 shares
Director @ $8.75 ($6.8K)
Apr 1, 2026
Insider
Flores Lorenzo sold 651.56 shares
Director @ $8.75 ($5.7K)
Inst.
TWO SIGMA INVESTMENTS, LP — EXIT
0 shares ($0.00)
Inst.
TWO SIGMA INVESTMENTS, LP — DOUBLED
156,249 shares ($1.4M)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $32.4M | — |
| WELLS FARGO & COMPANY/MN | $25.3M | — |
| BANK OF AMERICA CORP | $5.4M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 1, 2026 | Harris Stayce | A | $4.9K |
| Apr 1, 2026 | Steinmetz Arthur | A | $6.8K |
| Apr 1, 2026 | Flores Lorenzo | A | $5.7K |
| Apr 1, 2026 | HUBBARD ROBERT | A | $6.9K |
| Apr 1, 2026 | Holloman James | A | $5.2K |
3 institutional holders with $63.1M total value (6,658,971 shares) as of 2025-Q4. Top holders: MORGAN, WELLS, BANK. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 3,419,184 | $32.4M | 51.3% | — |
| 2 | WELLS FARGO & COMPANY/MN | 2,667,340 | $25.3M | 40.1% | — |
| 3 | BANK OF AMERICA CORP /DE/ | 572,447 | $5.4M | 8.6% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | EXIT | 156,249 | 0 | -100.0% | $0.00 | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 76,025 | 156,249 | +105.5% | $1.4M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 76,025 | — | $675.9K | 2025-Q2 |
| CITADEL ADVISORS LLC | NEW | — | 103,634 | — | $891.3K | 2025-Q1 |
8 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Harris Stayce D. | Director | A | 555.94 | $8.75 | $4.9K |
| Apr 1, 2026 | Steinmetz Arthur Philip | Director | A | 781.81 | $8.75 | $6.8K |
| Apr 1, 2026 | Flores Lorenzo | Director | A | 651.56 | $8.75 | $5.7K |
| Apr 1, 2026 | HUBBARD ROBERT GLENN | Director | A | 788.16 | $8.75 | $6.9K |
| Apr 1, 2026 | Holloman James Phillip | Director | A | 598.16 | $8.75 | $5.2K |
| Apr 1, 2026 | KESTER W CARL | Director | A | 75.7 | $8.75 | $662.38 |
| Jan 30, 2026 | Zhao David | M | 5,533.576 | $0.00 | $0.00 | |
| Jan 30, 2026 | Zhao David | D | 5,533.576 | $9.61 | $53.2K | |
| Jan 30, 2026 | Zhao David | A | 4,877.732 | $9.61 | $46.9K | |
| Jan 30, 2026 | Zhao David | M | 1,438.531 | $0.00 | $0.00 | |
| Jan 30, 2026 | McClements Kyle | M | 3,377.105 | $0.00 | $0.00 | |
| Jan 30, 2026 | McClements Kyle | D | 3,377.105 | $9.61 | $32.5K | |
| Jan 30, 2026 | McClements Kyle | A | 3,596.878 | $9.61 | $34.6K | |
| Jan 30, 2026 | McClements Kyle | M | 1,342.871 | $0.00 | $0.00 |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.